DeepSilencer: A Novel Deep Learning Model for Predicting siRNA Knockdown Efficiency
Background: Small interfering RNA (siRNA) is a promising therapeutic agent due to its ability to silence disease-related genes via RNA interference. While traditional machine learning and early deep learning methods have made progress in predicting siRNA efficacy, there remains significant room for improvement. Advanced deep learning techniques can enhance prediction accuracy, reducing the reliance on extensive wet-lab experiments and accelerating the identification of effective siRNA sequences. This approach also provides deeper insights into the mechanisms of siRNA efficacy, facilitating more targeted and efficient therapeutic strategies. Methods: We introduce DeepSilencer, an innovative deep learning model designed to predict siRNA knockdown efficiency. DeepSilencer utilizes advanced neural network architectures to capture the complex features of siRNA sequences. Our key contributions include a specially designed deep learning model, an innovative online data sampling method, and an improved loss function tailored for siRNA prediction. These enhancements collectively boost the model's prediction accuracy and robustness. Results: Extensive evaluations on multiple test sets demonstrate that DeepSilencer achieves state-of-the-art performance using only siRNA sequences and basic physicochemical properties. Our model surpasses several other methods and shows superior predictive performance, particularly when incorporating thermodynamic parameters. Conclusion: The advancements in data sampling, model design, and loss function significantly enhance the predictive capabilities of DeepSilencer. These improvements underscore its potential to advance RNAi therapeutic design and development, offering a powerful tool for researchers and clinicians.
Code (0)
등록된 구현이 없습니다.
Tasks
Deep LearningSimilar Papers 제목 키워드 기반
Targeted nanoconjugate co-delivering siRNA and tyrosine kinase inhibitor to KRAS mutant NSCLC dissociates GAB1-SHP2 post oncogene knockdown
A tri-block nanoparticle (TBN) comprising of an enzymatically cleavable porous gelatin nanocore encapsulated with gefitinib (tyrosine kinase inhibitor (TKI)) and surface functionalized with cetuximab-siRNA conjugate has …
Mesoporous core-shell silica nanoparticles with anti-fouling properties for ovarian cancer therapy
Mesoporous silica nanoparticles (MSNPs) have many potential applications in biomedical fields. However, when MSNPs are exposed to plasma, protein adsorption leads to opsonization and decreases blood circulation time. A n…
Uncertainty-Guided Model Selection for Tabular Foundation Models in Biomolecule Efficacy Prediction
In-context learners like TabPFN are promising for biomolecule efficacy prediction, where established molecular feature sets and relevant experimental results can serve as powerful contextual examples. However, their perf…
Machine Learning Modeling Of SiRNA Structure-Potency Relationship With Applications Against Sars-Cov-2 Spike Gene
The pharmaceutical Research and development (R&D) process is lengthy and costly, taking nearly a decade to bring a new drug to the market. However, advancements in biotechnology, computational methods, and machine learni…
Drug DiscoveryHighly Efficient siRNA Delivery from Core-Shell Mesoporous Silica Nanoparticles with Multifunctional Polymer Caps
A new general route for siRNA delivery is presented combining porous core-shell silica nanocarriers with a modularly designed multifunctional block copolymer. Specifically, the internal storage and release of siRNA from …